State Street’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-825
Closed -$10.1K 4630
2023
Q2
$10.1K Sell
825
-42
-5% -$536 ﹤0.01% 4644
2023
Q1
$12.4K Sell
867
-1,038
-54% -$19.5K ﹤0.01% 4732
2022
Q4
$28.6K Hold
1,905
﹤0.01% 4676
2022
Q3
$74K Sell
1,905
-158
-8% -$9.07K ﹤0.01% 4560
2022
Q2
$158K Sell
2,063
-2,342
-53% -$205K ﹤0.01% 4313
2022
Q1
$214K Sell
4,405
-293
-6% -$17.6K ﹤0.01% 4360
2021
Q4
$329K Buy
4,698
+998
+27% +$108K ﹤0.01% 4158
2021
Q3
$540K Buy
3,700
+2,100
+131% +$637K ﹤0.01% 3940
2021
Q2
$980K Buy
+1,600
New +$1.04M ﹤0.01% 3670

Other funds holding MDVL

State Street's MDVL Position: Q3 2023 in Review

State Street sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2023, closing a stake of 825 shares — an estimated $10.1K sold.

State Street first reported a position in MDVL in Q2 2021 and held it in 9 quarters. The position peaked at $980K in Q2 2021. 19 funds tracked by Wall St. Rank hold MDVL as of Q3 2023.

  • State Street reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • State Street sold 825 MedAvail Holdings, Inc. Common Stock shares in Q3 2023, an estimated $10.1K.
  • State Street first reported a position in MedAvail Holdings, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • State Street's MedAvail Holdings, Inc. Common Stock position peaked at $980K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.